Comprehensive prevention of age-related and cardiovascular diseases: the use of the Russian natural remedy BioDihydroquercetin of the Baikal Legend trade mark

DOI: https://doi.org/10.29296/25877305-2022-06-11
Issue: 
6
Year: 
2022

Professor D. Dedov, MD
Tver State Medical University
Tver Regional Clinical Cardiology Dispensary

Lifestyle is a major factor in aging, with the development of age-related and cardiovascular diseases (CVD) associated with accelerated aging. Prolongation of active longevity and reduction of morbidity are the most important goals of modern preventive and anti-aging medicine. Antioxidant drugs are used to prevent age-related diseases and CVD. The paper presents the results of trials of BioDihydroquercetin that is made under the Baikal Legend trademark using a unique technology and has a high antioxidant activity and bioavailability. The administration BioDihydroquercetin can reduce the influence of the major cardiovascular risk factors and thus improve life quality and expectancy in patients

Keywords: 
geriatrics
prevention
aging
lifestyle
geroprotectors
antioxidants
longevity
quality of life
age-related diseases
cardiovascular diseases
redox theory of aging
BioDihydroquercetin
Baikal Legend.



References: 
  1. Usoltseva O.N. Prevention of accelerated aging and "diseases of civilization" with natural geroprotectors BioChaga and BioDihydroquercetin. Meditsinskaya sestra. 2022; 3: 34–40 (in Russ.). DOI: 10.29296/25879979-2022-03-07
  2. Yakhno N.N., Tkacheva O.N., Gavrilova S.I. et al. Complex interdisciplinary and interdepartmental program of prevention, early detection, diagnosis and treatment of cognitive disorders in elderly and senile persons. Russian Journal of Geriatric Medicine. 2022; 1 (9): 6–16 (in Russ.). DOI: 10.37586/2686-8636-1-2022-6-16
  3. Malygina N.A. Cell aging and age-dependent diseases. Klinicheskaya gerontologiya. 2014; 20 (3–4): 30–4 (in Russ.).
  4. Tkacheva O.N., Kotovskaya Yu.V., Runikhina N.K. et al. Complex geriatric evaluation in elderly and senile patients with cardiovascular diseases. Expert Opinion of the Russian Association of Gerontologists and Geriatrics. Cardiology. 2021; 61 (5): 71–8 (in Russ.) DOI: 10.18087/cardio.2021.5.n1349
  5. Cruz-Jentoft A.J., Sayer A.A. Sarcopenia. Lancet. 2019; 393 (10191): 2636–46. DOI: 10.1016/S0140-6736(19)31138-9
  6. Hoogendijk E.O., Afilalo J., Ensrud K.E. et al. Frailty: implications for clinical practice and public health. Lancet. 2019; 394 (10206): 1365–75. DOI: 10.1016/S0140-6736(19)31786-6
  7. Batsis J.A., Zagaria A.B. Addressing Obesity in Aging Patients. Med Clin North Am. 2018; 102 (1): 65–85. DOI: 10.1016/j.mcna.2017.08.007
  8. Noren Hooten N., Brosh R.M. Jr. Ageing Research Reviews Special Issue dedicated to women in aging research. Ageing Res Rev. 2022; 77: 101589. DOI: 10.1016/j.arr.2022.101589
  9. Clinical practice guidelines for Stable coronary artery disease. Russian Journal of Cardiology. 2020; 25 (11): 4076 (in Russ.). DOI: 10.15829/1560-4071-2020-4076
  10. Kobalava Z.D., Konradi A.O., Nedogoda S.V. et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020; 25 (3): 3786 (in Russ.). DOI: 10.15829/1560-4071-2020-3-3786
  11. Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020; 25 (11): 4083 (in Russ.). DOI: 10.15829/1560-4071-2020-4083
  12. Drapkina O.M., Kontsevaya A.V., Kalinina A.M. et al. 2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022; 21 (4): 3235 (in Russ.). DOI: 10.15829/1728-8800-2022-3235
  13. Oganov R.G., Denisov I.N., Simanenkov V.I. et al. Comorbidities in practice. Clinical guidelines. Cardiovascular Therapy and Prevention. 2017; 16 (6): 5–56 (in Russ.). DOI: 10.15829/1728-8800-2017-6-5-56
  14. Clinical Recommendations «Cognitive Disorders in the Elderly and Older Adults». Approved by the Ministry of Health of the Russian Federation. 2020; 317 p. (in Russ.).
  15. Papanova E.K., Vorobyeva N.M., Kotovskaya Yu.V. et al. Healthy life expectancy of persons older than 65 years according to the Russian epidemiological survey EVKALYPT. Advances in Gerontology. 2022; 35 (2): 180–90 (in Russ.). DOI: 10.34922/AE.2022.35.2.002
  16. Titova T., Kudryashova L., Bolgova I. et al. Oxidative stress and aging: possible correction. Vrach. 2015; 6: 6–10 (in Russ.).
  17. Vasenina E.E., Levin O.S. Oxidizing stress in patogeneza of neurodegenerate diseases: possibilities of therapy. Sovremennaya terapiya v psikhiatrii i nevrologii. 2013; 3–4; 39–46 (in Russ.).
  18. Maxikova T.M., Kalaygin A.N., Usolceva O.N. et al. The possibility of using biodigidrokvertsetin for the prevention of cardiovascular disease in elderly persons engaged in the health groups. Siberian Medical Journal (Irkutsk). 2016; 141 (2): 34–39 (in Russ.).